Sepsis blood test with high accuracy may be coming to your hospital
www.pulmccm.org
In February 2017, the FDA approved Immunexpress's SeptiCyte, a molecular test with an indication for diagnosing sepsis on the first day of ICU treatment. The test isn't widely available, but that may change soon: the manufacturer announced a partnership with Biocartis, whose rapid-PCR testing platform could bring SeptiCyte into use in ICUs throughout the developed world.
Sepsis blood test with high accuracy may be coming to your hospital
Sepsis blood test with high accuracy may be…
Sepsis blood test with high accuracy may be coming to your hospital
In February 2017, the FDA approved Immunexpress's SeptiCyte, a molecular test with an indication for diagnosing sepsis on the first day of ICU treatment. The test isn't widely available, but that may change soon: the manufacturer announced a partnership with Biocartis, whose rapid-PCR testing platform could bring SeptiCyte into use in ICUs throughout the developed world.